Firms

ARCH Venture Partners

United States · New York · Wisconsin · New York, New York · Chicago, Illinois · San Diego, California · San Francisco, California · Seattle, Washington · Washington, District of Columbia · Boston, Massachusetts · Cambridge, Massachusetts · Palo Alto, California · Encinitas, California · San Carlos, California · San Francisco Bay Area · Chicago, Illinois, US

Signal profile (ARCH Venture Partners) ARCH Venture Partners cb ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories. ARCH has raised ten venturefunds totaling over $3 billion and has invested in the earliest venture capital rounds for more than 150 companies. ARCH investors include major corporations, pension funds, endowment funds, financial institutions, and private investors. SHOW MORE Founded: 1986

Founded: 1986
Type: Venture capital

Funds0

No funds on record yet.

Team

Robert Nelsen ARCH Venture Partners, Managing Director	$75M$50K – $150M	New York, New York
Vicki Sato ARCH Venture Partners, Venture Partner	$25M$50K – $150M	Cambridge, Massachusetts
Corey Ritter ARCH Venture Partners, Partner	$25M$50K – $150M	Chicago, Illinois
David Cruikshank ARCH Venture Partners, Venture Partner	$25M$50K – $150M	Chicago, Illinois
Keith Crandell ARCH Venture Partners, Managing Director	$25M$50K – $150M	Chicago, Illinois
Reetika Bhardwaj ARCH Venture Partners, Associate	$25M$50K – $150M	Chicago, Illinois
Sean Kendall ARCH Venture Partners, Partner	$25M$50K – $150M	Chicago, Illinois
Richard Heyman ARCH Venture Partners, Venture Partner	$25M$50K – $150M	Encinitas, California
Jay Markowitz ARCH Venture Partners, Partner	$25M$50K – $25M	New York
Joseph Jeong ARCH Venture Partners, Venture Partner	$25M$50K – $150M	Palo Alto, California
Keith Lenden ARCH Venture Partners, Venture Partner	$25M$50K – $150M	San Carlos, California
Jonathan Lim ARCH Venture Partners, Venture Partner	$25M$50K – $50M	San Diego, California
Carol Suh ARCH Venture Partners, Partner	$25M$50K – $150M	San Francisco Bay Area
Scott Minick ARCH Venture Partners, Managing Director	$25M$50K – $150M	San Francisco Bay Area
Ari Nowacek ARCH Venture Partners, Principal	$25M$50K – $150M	Seattle, Washington
Steven Gillis ARCH Venture Partners, Managing Director	$25M$50K – $150M	Seattle, Washington
Inca Dieterich ARCH Venture Partners, Venture Partner	$25M$50K – $150M	United States
Jay Parrish ARCH Venture Partners, Venture Partner	$25M$50K – $150M	United States
Nilay Thakar ARCH Venture Partners, Principal	$25M$50K – $150M	United States
Luciana Borio ARCH Venture Partners, Venture Partner	$25M$50K – $150M	Washington, District of Columbia
Paul Berns ARCH Venture Partners, Managing Director	$25M$50K – $150M	Wisconsin
Peter Mintun ARCH Venture Partners, Investor (Signal team listing)	$1M$100K – $5M	Boston, Massachusetts
Jay Kocherlakota ARCH Venture Partners, Senior Associate	$1M$100K – $5M	San Francisco, California
Sabah Oney ARCH Venture Partners, Venture Partner	$150K$100K – $5M	San Francisco Bay Area
Kristina Burow ARCH Venture Partners, Managing Director	$50K$50K – $150M	United States

Operations and support

Brian CuneoSenior Partner

Clinton BybeeCo-founder & Managing Director, Emeritus

David MooreSenior Partner

Jake BauerVenture Partner

Jason DorenGeneral Counsel

Jordan ZwickVenture Partner

Kevin HrusovskyVenture Partner

Mark McDonnellManaging Director, CFO & CAO

Olivia ZetterStrategic Advisor & Venture Partner

Patrick WeissVenture Partner

Paul ThurkManaging Director (1970-2021)

Peter Mintun, Ph.DAssociate

Steve LazarusCo-Founder & Managing Director (1931-2018)

Su FuAffiliate

Co-investing

F-Prime Capital

Polaris Partners

Casdin Capital

Investments

$200M2025-11-06	Synchron	Double Point Ventures, ARCH Venture Partners, Khosla Ventures, Bezos Expeditions, Neuro Technology Investors, METIS, National Reconstruction Fund Corporation, T.Rx Capital, Qatar Investment Authority, K5 Global, Protocol Labs, In-Q-Tel
$75M2022-12-15	Synchron	ARCH Venture Partners, Bezos Expeditions, Khosla Ventures, Gates Frontier, Reliance Digital Health, Greenoaks, Alumni Ventures, Moore Strategic Ventures, Project X, Neuro Technology Investors, METIS, Forepont Capital Partners, ID8 Investments, Shanda Group, University of Melbourne
$188M2026-08-06	LifeMine	ARCH Venture Partners, MRL Ventures Fund, GV, Bezos Expeditions, RA Capital Management, Gates Frontier
$107M2026-06-25	Trase	ARCH Venture Partners, Red Cell Partners, Quadri Ventures
$330M2026-06-24	Ollin	ARCH Venture Partners, T. Rowe Price, Mubadala Ventures, RA Capital Management, Canada Pension Plan Investment Board, Commodore Capital
$99M2026-06-08	City Therapeutics	ARCH Venture Partners, Casdin Capital, Viking Global Investors, Fidelity Investments, Sofinnova Partners, Rock Springs Capital
$122M2026-05-14	Create Medicines	ARCH Venture Partners, 8VC, Alexandria Venture Investments, Newpath Partners
$20M2026-04-30	Moleculent AB	ARCH Venture Partners
$250M2026-01-12	Mirador Tx	ARCH Venture Partners, Fidelity Management & Research Company, Logos Capital, Farallon Capital Management, Venrock Healthcare Capital Partners, Blue Owl Healthcare Opportunities
$48M2026-01-08	Vizgen	ARCH Venture Partners, Northpond Ventures, M Ventures
$27M2026	Lightcast Bio	ARCH Venture Partners, +ND Capital, M Ventures, Illumina Ventures
$330M2026	Ollin Biosciences	ARCH Venture Partners, T. Rowe Price, Mubadala Ventures, RA Capital Management, Canada Pension Plan Investment Board, Commodore Capital
$122M2026	Create Medicines	ARCH Venture Partners, 8VC, Alexandria Venture Investments, Newpath Partners
$99M2026	City Therapeutics	ARCH Venture Partners
$78M2025-12-04	Paradigm Health	ARCH Venture Partners, DFJ Growth, GV, F-Prime Capital, General Catalyst, Mubadala Ventures, Lux Capital
$53M2025-12-04	SciNeuro Pharmaceuticals	ARCH Venture Partners, LAV
$115M2025-11-20	Aspen Neuroscience	ARCH Venture Partners, S32, Axon Partners Group, OrbiMed, Cormorant Asset Management, Lifeforce Capital, Kite, a Gilead Company
$115M2025-11-20	Aspen Neuroscience	ARCH Venture Partners, S32, Axon Partners Group, Cormorant Asset Management, Lifeforce Capital, Avon Ventures, Kite, a Gilead Company, Section 32
$—2025-11-19	Lifordi Immunotherapeutics	ARCH Venture Partners, Atlas Venture, Sanofi Ventures, AMD Ventures
$65M2025-11-13	Gate Bioscience	ARCH Venture Partners, GV, Forbion, Versant Ventures, Eli Lilly and Company, Vineeta Agarwala
$40M2025-11-06	Elephas	ARCH Venture Partners, Tao Capital Partners, Northpond Ventures, Sands Capital
$40M2025-11-06	Elephas Biosciences	ARCH Venture Partners, Tao Capital Partners, Northpond Ventures, SV Health Investors, Sands Capital
$120M2025-10-15	Pelage	ARCH Venture Partners, GV, Main Street Advisors, Visionary Ventures, YK Bioventures
$254M2025-10-14	Kardigan	ARCH Venture Partners, Perceptive Advisors
$—2025-09-04	Treeline Biosciences	ARCH Venture Partners, KKR, GV, OrbiMed, Primary Venture Partners
$216M2025-07-23	Dispatch Bio	ARCH Venture Partners, Alexandria Venture Investments, Stanford University, Bristol Myers Squibb
$216M2025-07-23	Dispatch Biotherapeutics	ARCH Venture Partners, Alexandria Venture Investments, Stanford University, Bristol Myers Squibb
$73M2025-03-18	Arbor Biotechnologies	ARCH Venture Partners, Temasek Holdings (Private) Limited, ENIAC Ventures, T. Rowe Price, HPS Investment Partners, LLC, Revelation Partners
$86M2025-01-10	RhyGaze AG	ARCH Venture Partners, F-Prime Capital, BioGeneration Ventures
$200M2025-01-08	Tenvie	ARCH Venture Partners, F-Prime Capital, Mubadala Ventures
$200M2025-01-08	Tenvie Therapeutics	ARCH Venture Partners, F-Prime Capital
$250M2025	Mirador Therapeutics	ARCH Venture Partners, Alexandria Venture Investments, Logos Capital, Farallon Capital Management, Sanofi Ventures, Venrock Healthcare Capital Partners
$—2024-11-13	Metsera	ARCH Venture Partners, Wellington Management, Viking Global Investors, Alpha Wave Global, GV, Venrock Healthcare Capital Partners
$225M2024-10-21	Seaport Therapeutics	ARCH Venture Partners, T. Rowe Price, General Atlantic, Canada Pension Plan Investment Board, Sofinnova Partners, Third Rock Ventures
$—2024-10-08	City Therapeutics	ARCH Venture Partners, The Invus Group, LLC, Rock Springs Capital
$325M2024-09-04	Arsenal Biosciences	ARCH Venture Partners, NVIDIA Corporation, Bristol Myers Squibb, Regeneron Pharmaceuticals, Sixth Street Growth
$325M2024-09-04	ArsenalBio	ARCH Venture Partners, Kleiner Perkins, NVentures, Westlake Village BioPartners, Hitachi Ventures, Bristol Myers Squibb
$100M2024-07-23	Autobahn	ARCH Venture Partners, Canaan Partners, Insight Partners, Newpath Partners, Bristol Myers Squibb, Monograph Capital
$100M2024-07-23	Autobahn Therapeutics	ARCH Venture Partners, Canaan Partners, Insight Partners, Newpath Partners, Bristol Myers Squibb, Monograph Capital
$20M2024-06-11	Moleculent AB	ARCH Venture Partners
$71M2024-06-04	Vilya	ARCH Venture Partners, Menlo Ventures, Madrona Venture Group, Altitude Life Science Ventures, Lifeforce Capital
$71M2024-06-04	Vilya Therapeutics	ARCH Venture Partners, Menlo Ventures, NVentures, Madrona Venture Group, Altitude Life Science Ventures, Lifeforce Capital
$1B2024-04-23	Xaira Therapeutics	ARCH Venture Partners
$1B2024-04-01	Xaira Therapeutics	ARCH Venture Partners, Primary Venture Partners, Foresite Capital
$400M2024-03-21	Mirador Tx	ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Logos Capital, Sanofi Ventures, Blue Owl Healthcare Opportunities
$55M2024-01-23	Elephas	ARCH Venture Partners, Tao Capital Partners, Northpond Ventures, Sands Capital, Moore Strategic Ventures
$55M2024-01-23	Elephas Biosciences	ARCH Venture Partners, Northpond Ventures, SV Health Investors, Sands Capital, Moore Strategic Ventures, AF Ventures
$95M2024-01-04	HI-Bio	ARCH Venture Partners, Viking Global Investors, Alpha Wave Global, Jeito Capital, Arkin Bio Ventures
$95M2024-01-04	Human Immunology Biosciences (HI-Bio)	ARCH Venture Partners, Viking Global Investors, Alpha Wave Global, Jeito Capital, Arkin Bio Ventures
$60M2024-01-03	Remix Therapeutics	ARCH Venture Partners, Casdin Capital, Atlas Venture, Alexandria Venture Investments, W.T.T. Investment Ltd., Surveyor Capital
$75M2024	nChroma	ARCH Venture Partners, Casdin Capital, Atlas Venture, Wellington Management, F-Prime Capital, Cormorant Asset Management
$26M2024	Matter Neuroscience	ARCH Venture Partners, Collaborative Fund, Exor Ventures, Polaris Partners
$325M2024	Arsenal Biosciences	ARCH Venture Partners, Kleiner Perkins, T. Rowe Price, Westlake Village BioPartners, Hitachi Ventures, Bristol Myers Squibb
$115M2024	Maze Therapeutics	ARCH Venture Partners, Casdin Capital, Andreessen Horowitz, Logos Capital, GV, General Catalyst, Moore Strategic Ventures
$213M2023-12-12	Tome Biosciences	ARCH Venture Partners, Alexandria Venture Investments, GV, Polaris Partners, Longwood Fund, FUJIFILM Corporation
$60M2023-11-01	Gate Bio	Versant Ventures, Andreessen Horowitz, ARCH Venture Partners, GV
$60M2023-11-01	Gate Bioscience	ARCH Venture Partners, GV, Versant Ventures, Vineeta Agarwala
$50M2023-09-19	Magnet Biomedicine	ARCH Venture Partners, Newpath Partners
$273M2023-09-15	Generate Biomedicines	ARCH Venture Partners, March Capital, T. Rowe Price, Fidelity Investments, Flagship Pioneering, Abu Dhabi Investment Authority
$150M2023-08-23	Rapport Therapeutics	ARCH Venture Partners, The Goldman Sachs Group, Inc., T. Rowe Price, Logos Capital, Fidelity Investments, Cormorant Asset Management
$49M2023-08-18	Lightcast Discovery	ARCH Venture Partners, +ND Capital, OKX Ventures, M Ventures, Illumina Ventures
$38M2023-08-17	Lightcast	ARCH Venture Partners, +ND Capital, M Ventures, Illumina Ventures
$145M2023-06-07	Bitterroot Bio	ARCH Venture Partners, Alexandria Venture Investments, GV, Koch Disruptive Technologies, Deerfield
$73M2023-05-18	Myeloid Therapeutics	ARCH Venture Partners, 8VC, Alexandria Venture Investments, Moore Strategic Ventures, Primary Venture Partners, Newpath Partners
$270M2023-04-26	Orbital Therapeutics	ARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Andreessen Horowitz, Moore Strategic Ventures, Newpath Partners, Vineeta Agarwala
$135M2023-03-01	Chroma Medicine	ARCH Venture Partners, Casdin Capital, Atlas Venture, DCVC, Wellington Management, Cormorant Asset Management, Osage University Partners
$—2023-02-28	Paratus Sciences	ARCH Venture Partners, Leaps by Bayer, Alexandria Venture Investments, Polaris Partners, BECO Capital, ClavystBio
$—2023-01-30	Paradigm	ARCH Venture Partners, General Catalyst, F-Prime Capital, GV, Mubadala Ventures, Lux Capital, Magnetic
$100M2023	Rapport	ARCH Venture Partners, Third Rock Ventures, Johnson & Johnson Innovation, Wisdom Ventures
$38M2023	Lightcast Bio	ARCH Venture Partners, +ND Capital, M Ventures, Illumina Ventures
$145M2023	Bitterroot	ARCH Venture Partners, Alexandria Venture Investments, GV, Koch Disruptive Technologies, Deerfield
$150M2023	Rapport Therapeutics, Inc.	ARCH Venture Partners, The Goldman Sachs Group, Inc., T. Rowe Price, Logos Capital, Cormorant Asset Management, Sofinnova Partners
$18M2022-12-19	Protillion Biosciences	ARCH Venture Partners, Illumina Ventures
$25M2022-12-01	CARRICK THERAPEUTICS LIMITED	ARCH Venture Partners, Enterprise Ireland, Lightstone Ventures, Cambridge Innovation Capital, Pfizer Ventures
$16M2022-11-04	hC Bioscience	ARCH Venture Partners, 8VC, Panacea Venture, Takeda Ventures, Inc.
$120M2022-11-01	Human Immunology Biosciences (HI-Bio)	ARCH Venture Partners
$120M2022-11-01	Human Immunology Biosciences	ARCH Venture Partners
$32M2022-09-28	Rippl	ARCH Venture Partners, General Catalyst, F-Prime Capital, GV, Mass General Brigham Ventures
$72M2022-09-12	Pretzel	ARCH Venture Partners, Angelini Ventures, GV, Mubadala Ventures, The Invus Group, LLC, Sidekick Partners
$72M2022-09-12	Pretzel Therapeutics	ARCH Venture Partners, Angelini Ventures, GV, Alphabet Inc., Cambridge Enterprise, HealthCap
$60M2022-08-24	Happy Health	ARCH Venture Partners
$—2022-08-03	Homeward Health	ARCH Venture Partners, Human Ventures, General Catalyst
$200M2022-08-02	Sironax	ARCH Venture Partners, Temasek Holdings (Private) Limited, F-Prime Capital, Fidelity Management & Research Company, Yunfeng Capital, Abu Dhabi Investment Authority
$200M2022-08-02	Sironax	ARCH Venture Partners, Temasek Holdings (Private) Limited, F-Prime Capital, Eight Roads, Yunfeng Capital, Abu Dhabi Investment Authority
$85M2022-06-03	Vizgen	ARCH Venture Partners, Tao Capital Partners, Northpond Ventures, Blue Water Life Science Advisors, Novalis LifeSciences, Sofina
$147M2022-05-09	Aspen Neuroscience	ARCH Venture Partners, Mirae Asset, EDBI, Alexandria Venture Investments, S32, Lifeforce Capital
$76M2022-04-26	Pheast Therapeutics	ARCH Venture Partners, Catalio Capital Management, Alexandria Venture Investments
$60M2022-03-09	Colossal	ARCH Venture Partners, Bold Capital Partners, Breyer Capital, Animoca Brands, First Light Capital Group, Builders VC
$150M2022-02-03	DewPoint Therapeutics, Inc.	General Catalyst, 3E Bioventures Capital, NS Investment, Leaps by Bayer, Polaris Partners, Samsara BioCapital, ARCH Venture Partners, Mirae Asset Capital, Maverick Ventures, Mubadala Capital
$150M2022-02-03	Dewpoint Therapeutics	ARCH Venture Partners, Leaps by Bayer, Maverick Ventures, Mirae Asset, General Catalyst, BECO Capital, 3E Bioventures Capital, Elena Viboch
$75M2022-01-20	ONI	ARCH Venture Partners, Casdin Capital, S32, Axon Partners Group, The Vertical Group, Oxford Science Enterprises, Section 32
$3B2022-01-19	Altos Labs	ARCH Venture Partners
$150M2022	Dewpoint	ARCH Venture Partners, Leaps by Bayer, Maverick Ventures, Mirae Asset, General Catalyst, 3E Bioventures Capital, NS Investment
$25M2022	CARRICK THERAPEUTICS LIMITED	ARCH Venture Partners, Enterprise Ireland, Lightstone Ventures, Cambridge Innovation Capital
$370M2021-11-18	Generate Biomedicines Inc	Flagship Pioneering, Abu Dhabi Investment Authority, Alaska Permanent Fund, Altitude Life Science Ventures, ARCH Venture Partners, Fidelity Management & Research Company, Morningside Ventures, T. Rowe Price Associates
$215M2021-11-09	Arbor Biotechnologies	ARCH Venture Partners, TCV, Temasek Holdings (Private) Limited, Tao Capital Partners, Redpoint Ventures, S32, Illumina Ventures, Section 32
$55M2021-10-26	Mozart Therapeutics	ARCH Venture Partners, MRL Ventures Fund, Leaps by Bayer, Alexandria Venture Investments, Altitude Life Science Ventures, Sofinnova Partners
$—2021-10-07	Neumora Therapeutics, Inc.	ARCH Venture Partners, Catalio Capital Management, F-Prime Capital, Alexandria Venture Investments, Polaris Innovation Fund, re.Mind Capital
$50M2021-09-21	Cytrellis	ARCH Venture Partners, D1 Capital Partners, Sands Capital, PFM Health Sciences
$50M2021-09-21	Cytrellis Biosystems	ARCH Venture Partners, D1 Capital Partners, Sands Capital, PFM Health Sciences, Primary Venture Partners
$265M2021-08-04	Sonoma Biotherapeutics	ARCH Venture Partners, 8VC, Casdin Capital, Mirae Asset, Lifeforce Capital, Vertex Ventures HC, Osage University Partners
$200M2021-07-13	Prime Medicine, Inc.	ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant Asset Management, Moore Strategic Ventures, PSP Investments, Redmile Group, Samsara BioCapital, T. Rowe Price Associates
$200M2021-07-13	Prime Medicine	ARCH Venture Partners, F-Prime Capital, GV
$67M2021-05-19	HiberCell	ARCH Venture Partners, Hercules Capital, Inc., Magnetic, Bristol Myers Squibb, Tekla Capital Management, Raptor Group
$139M2021-04-13	Jaguar Gene Therapy	ARCH Venture Partners, The Goldman Sachs Group, Inc., Eli Lilly and Company, Deerfield
$37M2021-04-07	Vizgen	ARCH Venture Partners, Tao Capital Partners, Northpond Ventures, Novalis LifeSciences, Pura Vida Investments
$75M2021-01-27	Encodia	ARCH Venture Partners, Tao Capital Partners, Northpond Ventures, Alexandria Venture Investments, GV, Decent Capital
$40M2021	OncoResponse, Inc.	ARCH Venture Partners, Canaan Partners, Redmile Group, RiverVest Venture Partners, 3B Future Health Fund, Magnetar Capital
$—2021	Recuro Health	ARCH Venture Partners
$139M2021	Jaguar Gene Therapy	ARCH Venture Partners, The Goldman Sachs Group, Inc., Eli Lilly and Company, Deerfield
$81M2020-12-08	Remix Therapeutics	ARCH Venture Partners, Atlas Venture, Alexandria Venture Investments, Foresite Capital, The Column Group
$750M2020-11-23	Resilience	ARCH Venture Partners, 8VC, New Enterprise Associates, GV, Primary Venture Partners
$60M2020-09-23	Nutcracker Therapeutics	ARCH Venture Partners, Primary Venture Partners, Bluebird Ventures
$41M2020-06-14	Bit Bio	ARCH Venture Partners, BlueYard Capital, Foresite Capital
$76M2020-06-09	Autobahn Therapeutics	ARCH Venture Partners, Alexandria Venture Investments, Bristol Myers Squibb, BVF Partners L.P., Cowen Healthcare Investments, Samsara BioCapital
$100M2020-05-21	Mindstrong Health	ARCH Venture Partners, 8VC, General Catalyst, What If Ventures, Bezos Expeditions, Optum Ventures
$70M2020-04-01	Aspen Neuroscience	ARCH Venture Partners, S32, OrbiMed, Domain Associates, Frazier Healthcare Partners, Section 32
$60M2020-01-09	Omniome	ARCH Venture Partners, Mangrove Capital Partners, Decent Capital, Domain Associates, Altitude Life Science Ventures, Pivotal Life Sciences
$100M2020-01-08	Transcenta Holding	ARCH Venture Partners, Temasek Holdings (Private) Limited, Sequoia Capital, Sequoia
$100M2020	Mindstrong Health	ARCH Venture Partners, 8VC, General Catalyst, What If Ventures, Bezos Expeditions, Optum Ventures
$493M2020	Lyell Immunopharma	ARCH Venture Partners, Foresite Capital
$85M2019-12-18	Epirium Bio	ARCH Venture Partners, Adams Street Partners, Cormorant Asset Management, Bluebird Ventures, Vertex Ventures HC, Longitude Capital
$6M2019-12-12	Aspen Neuroscience	ARCH Venture Partners, Alexandria Venture Investments, S32, Axon Partners Group, OrbiMed, Domain Associates, Section 32
$104M2019-06-26	Encoded Therapeutics	ARCH Venture Partners, Venrock, Menlo Ventures, Alexandria Venture Investments, Illumina Ventures, RTW Investments, LP
$55M2019-05-22	Locana	ARCH Venture Partners, Temasek Holdings (Private) Limited, GV, Lightstone Ventures, Primary Venture Partners, UCB Ventures
$82M2019-04-30	Vividion Therapeutics	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Mubadala Ventures, Celgene
$—2019-04-29	908 Devices	ARCH Venture Partners, Casdin Capital, Hercules Capital, Inc., Tao Capital Partners, Northpond Ventures, Razor's Edge Ventures
$68M2019	Karuna Therapeutics	ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Eventide Asset Management, Partner Fund Management, Pivotal bioVenture Partners
$10M2019	Ally Therapeutics	ARCH Venture Partners, Alta Partners, UCB Ventures
$22M2019	Ultivue	ARCH Venture Partners, Northpond Ventures
$85M2019	Epirium Bio	ARCH Venture Partners, Adams Street Partners, Bluebird Ventures, Vertex Ventures HC, Longitude Capital, The Longevity Fund
$179M2019	Lyell Immunopharma	ARCH Venture Partners, Foresite Capital
$80M2018-09-28	KSQ Therapeutics	ARCH Venture Partners, Flagship Pioneering, Baillie Gifford, Polaris Partners, Cowen Healthcare Investments, The Invus Group, LLC
$40M2018-09-11	OncoResponse, Inc.	ARCH Venture Partners, Alexandria Venture Investments, Canaan Partners, Qatar Investment Authority, Redmile Group, RiverVest Venture Partners
$40M2018-09-11	OncoResponse	ARCH Venture Partners, Alexandria Venture Investments, Canaan Partners, Qatar Investment Authority, Redmile Group, RiverVest Venture Partners
$—2018-08-29	Nebula Genomics	Khosla Ventures, ARCH Venture Partners, F-Prime Capital, Redpoint Ventures, Mirae Asset, Windham Capital Partners
$31M2018-08-14	Magnolia Neurosciences	ARCH Venture Partners, Alexandria Venture Investments, AbbVie, Eli Lilly and Company, Partnership Fund for New York City, Pfizer Ventures
$65M2018-07-17	AgBiome	ARCH Venture Partners, Fidelity Investments, Polaris Partners, Primary Venture Partners, Pontifax Global Food and Agriculture Technology Fund
$—2018-05-24	Brii Biosciences	ARCH Venture Partners, Blue Pool Capital, Sequoia Capital, Sequoia, Boyu Capital, Yunfeng Capital
$45M2018-05-15	Nohla Therapeutics	ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Celgene, Premier Partners
$260M2018-05-09	CStone Pharmaceuticals	ARCH Venture Partners, Dimension, WuXi AppTec, Boyu Capital, Yunfeng Capital, CPE
$4M2018-05-08	Luna DNA	ARCH Venture Partners, Primary Venture Partners, Illumina Ventures, Hemisphere Ventures
$117M2018-03-27	Hua Medicine	ARCH Venture Partners, Venrock, GIC Private Limited, F-Prime Capital, Eight Roads, Blue Pool Capital
$42M2018	Karuna Therapeutics	ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Eventide Asset Management, Partner Fund Management, Pivotal bioVenture Partners
$35M2018	Hangzhou Just Biotherapeutics	ARCH Venture Partners, Temasek Holdings (Private) Limited, LAV
$76M2017-11-29	Codiak Biosciences	ARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Alaska Permanent Fund Corporation, BECO Capital, Ona Capital
$55M2017-09-18	LifeMine Therapeutics	ARCH Venture Partners, MRL Ventures Fund, Alexandria Venture Investments, GV, WuXi AppTec, Boyu Capital
$40M2017-04-27	Sienna Biopharmaceuticals	ARCH Venture Partners, Fidelity Management & Research Company, Altitude Life Science Ventures
$22M2017-03	OncoResponse	ARCH Venture Partners, Canaan Partners
$20M2017-01-10	Aledade	ARCH Venture Partners, Venrock, GV, Primary Venture Partners, Maryland Venture Fund, Biomatics Capital
$150M2017-01-06	Vir Biotechnology	ARCH Venture Partners, Gates Foundation
$40M2017	Sienna Biopharmaceuticals	ARCH Venture Partners, Altitude Life Science Ventures
$20M2016-12-06	Elysium Health	General Catalyst, ARCH Venture Partners, Primary Venture Partners
$—2016-11-29	Nohla Therapeutics	ARCH Venture Partners, Alexandria Venture Investments
$116M2016-10-27	Unity Biotechnology	ARCH Venture Partners, Venrock, Baillie Gifford, Bezos Expeditions, Mayo Clinic Ventures
$40M2016-10-26	Genomics Medicine Ireland	ARCH Venture Partners, GV, Polaris Partners, Ireland Strategic Investment Fund
$95M2016-10-03	Carrick Therapeutics	ARCH Venture Partners, GV, Lightstone Ventures, Primary Venture Partners, Cambridge Enterprise, Cambridge Innovation Capital
$48M2016-01-06	Petra Pharma	ARCH Venture Partners, Alexandria Venture Investments, AbbVie, Eli Lilly and Company, Partnership Fund for New York City, Pfizer Ventures
$36M2016-01-04	Scholar Rock	ARCH Venture Partners, Fidelity Investments, Polaris Partners, BECO Capital, Cormorant Asset Management, The Kraft Group
$15M2016	JUST Biotherapeutics	ARCH Venture Partners, Bill & Melinda Gates Foundation, Lilly Asia Ventures, Merck
$80M2015-11-17	Codiak Biosciences	ARCH Venture Partners, Alexandria Venture Investments, Fidelity Investments, Flagship Pioneering, Primary Venture Partners, Alaska Permanent Fund Corporation
$217M2015-05-14	Denali Therapeutics	ARCH Venture Partners, F-Prime Capital, Flagship Pioneering, Primary Venture Partners, Alaska Permanent Fund Corporation
$15M2015	JUST Biotherapeutics	ARCH Venture Partners, Lilly Asia Ventures, Merck
$40M2015	Movidius	ARCH Venture Partners, Atlantic Bridge, Robert Bosch Venture Capital, DFJ Esprit, Celtic House Venture Partners, e& capital, Bosch Ventures
$53M2014-10-27	Syros Pharmaceuticals	ARCH Venture Partners, Polaris Partners, Redmile Group
$176M2014-04-24	Juno Therapeutics	ARCH Venture Partners, Venrock, Bezos Expeditions, Alaska Permanent Fund Corporation, Crestline Investors
$37M2013-09	Sage Therapeutics	ARCH Venture Partners, Third Rock Ventures
$60M2012-07-25	bluebird bio	ARCH Venture Partners, Sanofi Ventures, Forbion, Deerfield, Third Rock Ventures
$18M2012	Quanterix	ARCH Venture Partners, Hercules Capital, Inc., In-Q-Tel
$37M2011-09-19	Kythera Biopharmaceuticals	ARCH Venture Partners, Altitude Life Science Ventures, Versant Ventures, JAFCO Group Co., Ltd.
$78M2011	Agios	ARCH Venture Partners, Celgene, Third Rock Ventures, Flagship Ventures
$25M2010-01-12	VentiRx Pharmaceuticals, Inc.	ARCH Venture Partners, Domain Associates, Frazier Healthcare Partners
$8M2010	Agios	ARCH Venture Partners, Third Rock Ventures, Flagship Ventures
$12M2009	Elixir Pharmaceuticals	ARCH Venture Partners, Hercules Capital, Inc., Omega Funds, MPM Capital
$33M2008-07-07	Agios Pharmaceuticals	ARCH Venture Partners, Third Rock Ventures
$15M2008	Agios	ARCH Venture Partners, Third Rock Ventures, Flagship Ventures
$15M2008	Quanterix	ARCH Venture Partners, Bain Capital Ventures, Hercules Capital, Inc., Bain Capital
$19M2007-03-07	Impinj	ARCH Venture Partners, Unilever Ventures, Polaris Partners, Madrona Venture Group
$19M2007	Impinj Inc	ARCH Venture Partners, Unilever Ventures, Polaris Partners, Madrona Venture Group, UPS
$—2007	VentiRx Pharmaceuticals, Inc.	ARCH Venture Partners, Domain Associates, Frazier Healthcare Partners
$26M2005	Impinj Inc	ARCH Venture Partners, Unilever Ventures, Polaris Partners, Madrona Venture Group, UPS
$22M2004	Impinj Inc	ARCH Venture Partners, Unilever Ventures, Polaris Partners, Madrona Venture Group, UPS
$11M2004	Vascular Architects, Inc.	ARCH Venture Partners, Western Technology Investment, Domain Associates
$15M2003-09-24	Infinicon	Chevron Technology Ventures, W Capital Partners, ARCH Venture Partners, Bay Partners
$12M2002	MedVantx	ARCH Venture Partners, Advent International, Polaris Partners
$150MUnknown date	Rapport	ARCH Venture Partners, Fidelity Management & Research Company, T. Rowe Price, Logos Capital, Cormorant Asset Management, Sofinnova Partners
$65MUnknown date	Gate Bio	ARCH Venture Partners, GV, Forbion, Versant Ventures, Eli Lilly and Company, Andreessen Horowitz (a16z) Bio + Health
$150MUnknown date	DewPoint Therapeutics, Inc.	ARCH Venture Partners, Leaps by Bayer, Maverick Ventures, Mirae Asset, General Catalyst, 3E Bioventures Capital, NS Investment
$17MUnknown date	Cooledge	ARCH Venture Partners, Yaletown Partners
$63MUnknown date	Omeros Corporation	ARCH Venture Partners, Foresite Capital, WRF Capital, Novartis Venture Fund
$120MUnknown date	Pelage	ARCH Venture Partners, YK Bioventures, Visionary Ventures, Main Street Advisors
$48MUnknown date	Vizgen Corp.	ARCH Venture Partners, Northpond Ventures, M Ventures, Pura Vida Investments
$45MUnknown date	Proof Diagnostics	ARCH Venture Partners, F-Prime Capital, Madrona Venture Group
$—Unknown date	Sage Therapeutics	ARCH Venture Partners, Third Rock Ventures
$21MUnknown date	Novella	ARCH Venture Partners, Blank Ventures, Avid Ventures, Crystal Venture Partners, Verissimo Ventures, Brewer Lane Ventures
$15MUnknown date	Infinicon	ARCH Venture Partners, Chevron Technology Ventures, Bay Partners
$100MUnknown date	Singleron Biotechnologies	ARCH Venture Partners, Sherpa Healthcare Partners, CDH Investments, Lake Bleu Capital, Lilly Asia Ventures
$60MUnknown date	Nutcracker	ARCH Venture Partners, +ND Capital, Bluebird Ventures
$5MUnknown date	Shocking Technologies	ARCH Venture Partners, Hercules Capital, Inc.
$60MUnknown date	Quantum Circuits Inc.	ARCH Venture Partners, Tao Capital Partners, F-Prime Capital, Connecticut Innovations, Canaan Partners, Sequoia, Tribeca Venture Partners
$—Unknown date	Prime Medicine, Inc.	ARCH Venture Partners, Casdin Capital, F-Prime Capital, T. Rowe Price, Cormorant Asset Management, Public Sector Pension Investment Board
$—Unknown date	Prime Medicine, Inc.	ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Samsara BioCapital
$61MUnknown date	Codiak Biosciences	ARCH Venture Partners, Alexandria Venture Investments, Fidelity Investments, Alaska Permanent Fund Corporation
$10MUnknown date	Boragen	ARCH Venture Partners, Alexandria Venture Investments, Flagship Pioneering, Pappas Capital, Mountain Group Partners, Syngenta Group Ventures
$200MUnknown date	EQRx	ARCH Venture Partners, Andreessen Horowitz, GV
$60MUnknown date	Quantum Circuits	ARCH Venture Partners, Tao Capital Partners, F-Prime Capital, Fidelity Investments, Connecticut Innovations, Sequoia, Tribeca Venture Partners
$11MUnknown date	RhyGaze AG	ARCH Venture Partners, BioGeneration Ventures
$26MUnknown date	Enumerix	ARCH Venture Partners, F-Prime Capital
$50MUnknown date	ImmuneID	ARCH Venture Partners, Alexandria Venture Investments, Xfund, In-Q-Tel, Longwood Fund, Tekla Capital Management
$273MUnknown date	Generate Biomedicines Inc	ARCH Venture Partners, March Capital, Mirae Asset, T. Rowe Price, Flagship Pioneering, Abu Dhabi Investment Authority
$44MUnknown date	Volastra	ARCH Venture Partners, Catalio Capital Management, Polaris Partners
$47MUnknown date	Recuro Health	ARCH Venture Partners
$15MUnknown date	Recuro Health	ARCH Venture Partners, 1843 Capital
$60MUnknown date	HiberCell	ARCH Venture Partners, Celgene, Raptor Group
$7MUnknown date	Comeryx	ARCH Venture Partners, American Family Ventures, Boulder Ventures, Intact Ventures
$300MUnknown date	Oratomic	ARCH Venture Partners, Bain Capital Ventures, Lowercarbon Capital, General Catalyst, Bain Capital, Index Ventures, Khosla Ventures, Nebular, Genius Ventures
$14MUnknown date	BlackThorn Therapeutics	ARCH Venture Partners, Mercury Fund, GV, Biomatics Capital, Altitude Life Science Ventures
$82MUnknown date	Vividion	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Mubadala Ventures, Celgene
$273MUnknown date	Generate:Biomedicines	ARCH Venture Partners, March Capital, Mirae Asset, T. Rowe Price, Flagship Pioneering, Abu Dhabi Investment Authority
$100MUnknown date	Singleron	ARCH Venture Partners, LAV, Sherpa Healthcare Partners, CDH Investments, Lake Bleu Capital
$11MUnknown date	Slingshot Biosciences	ARCH Venture Partners, Northpond Ventures
$26MUnknown date	Countable Labs	ARCH Venture Partners, F-Prime Capital, Fidelity Investments
$72MUnknown date	Rome	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Y Combinator, Sanofi Ventures, Mass General Brigham Ventures
$90MUnknown date	Syndeio Biosciences	ARCH Venture Partners, Catalio Capital Management, AbbVie, Eli Lilly and Company, Palo Santo, Tenmile
$114MUnknown date	Semma Therapeutics	ARCH Venture Partners, F-Prime Capital, Fidelity Investments, Cowen Healthcare Investments, MPM Capital, Medtronic
$—Unknown date	Agios Pharmaceuticals	ARCH Venture Partners
$60MUnknown date	Volastra Therapeutics	ARCH Venture Partners, Catalio Capital Management, Polaris Partners, Cormorant Asset Management, Eli Lilly and Company
$44MUnknown date	Volastra Therapeutics	ARCH Venture Partners, Catalio Capital Management, Polaris Partners, Cormorant Asset Management
$57MUnknown date	Moonwalk Biosciences	ARCH Venture Partners, Alpha Wave Global, GV, Future Fund, Alphabet Inc., Khosla Ventures, YK Bioventures
$55MUnknown date	Basking Biosciences	ARCH Venture Partners, Insight Partners, Rev1 Ventures
$75MUnknown date	Areteia Therapeutics	ARCH Venture Partners, Maverick Ventures, Viking Global Investors, GV, Alphabet Inc., Bain Capital, Sanofi Ventures
$112MUnknown date	Neumora Therapeutics	ARCH Venture Partners, F-Prime Capital, Exor Ventures, Mubadala Ventures, Altitude Life Science Ventures, Premier Partners
$46MUnknown date	Quanterix	ARCH Venture Partners, Bain Capital Ventures, Hercules Capital, Inc., Bain Capital, Cormorant Asset Management
$60MUnknown date	AiRNA	ARCH Venture Partners, +ND Capital, Alexandria Venture Investments, Forbion, Ono Venture Investment
$155MUnknown date	AiRNA	ARCH Venture Partners, +ND Capital, Alexandria Venture Investments, Forbion, Venrock Healthcare Capital Partners, Nextech Invest Ltd.
$25MUnknown date	Hua Medicine	ARCH Venture Partners, Venrock, F-Prime Capital, Fidelity Investments, Ally Bridge Group
$65MUnknown date	Metacrine	ARCH Venture Partners, Franklin Templeton, Alexandria Venture Investments, Polaris Partners, venBio, Venrock Healthcare Capital Partners
$193MUnknown date	Aera Therapeutics	ARCH Venture Partners, GV, Alphabet Inc., Lux Capital
$193MUnknown date	Aera Therapeutics	ARCH Venture Partners, GV, Alphabet Inc., Lux Capital
$125MUnknown date	SonoThera	ARCH Venture Partners, Leaps by Bayer, Alexandria Venture Investments, Duquesne Family Office, Illumina Ventures, Vertex Ventures HC
$26MUnknown date	Twist Bioscience	ARCH Venture Partners, Paladin Capital Group, B37
$305MUnknown date	Parabilis Medicines	ARCH Venture Partners, Alphabet Inc., RA Capital Management, Cormorant Asset Management, Soleus Capital
$—Unknown date	Gossamer Bio	ARCH Venture Partners, Polaris Partners
$—Unknown date	Sana Biotechnology	ARCH Venture Partners, F-Prime Capital, GV, Alaska Permanent Fund Corporation, Canada Pension Plan Investment Board, Omega Funds
$191MUnknown date	eGenesis	Leaps by Bayer, Polaris Partners, Lux Capital, DaVita Venture Group, Farallon Capital Management, Alta Partners, Khosla Ventures, ARCH Venture Partners
$4M2019-05-08	LunaPBC	ARCH Venture Partners, Bain Capital Ventures, F-Prime Capital, Bain Capital, Illumina Ventures, Osage University Partners
$12M2015-07-24	Voxel8	ARCH Venture Partners, Autodesk, In-Q-Tel, Osage University Partners, Braemar Energy Ventures